- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
NEJM Study Could Influence Medicare Coverage of CT Screening in Lung Cancer
The study results from the National Lung Screening Trial found cost-effectiveness and value of screening long-term smokers when screened by trained professionals.
Lung cancer screening with CT scans can be cost-effective while saving lives, a new study suggests.
But, there are two caveats to that finding -- the procedure has to be performed by skilled professionals and the screening must be done on a very specific set of long-time smokers, the researchers noted.
Results from the National Lung Screening Trial (NLST) showed four years ago that annual CT scans can reduce lung cancer deaths by 20 percent in older, long-time smokers.
The new study, which uses data gathered during that national trial, concludes that screening for lung cancer would cost $81,000 for each year of quality life gained -- lower than the generally accepted $100,000-per-year threshold for cost effectiveness.
Link to the complete report: http://1.usa.gov/13Rsylv
Source: MedlinePlus
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
FDA Approves Danziten for Chronic Myeloid Leukemia Without Mealtime Restrictions
November 14th 2024The FDA has granted approval to Azurity Pharmaceuticals' nilotinib tablets (Danziten), a novel version of the tyrosine kinase inhibitor for chronic myeloid leukemia that can be taken without mealtime restrictions.
Read More
Bridging Cancer Care Gaps and Overcoming Medical Mistrust
November 13th 2024In this clip from our interview with Oscar B. Lahoud, MD, cochair of our Institute for Value-Based Medicine® evening hosted with NYU Langone Health, he addressed medical mistrust in underrepresented communities.
Read More
